- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03948113
Outcome of Autosomal Dominant Polycystic Kidney Disease Patients on Peritoneal Dialysis: a National Retrospective Study Based on Two French Registries (the French Language Peritoneal Dialysis Registry and the French Renal Epidemiology and Information Network). (ADPKDPD)
May 10, 2019 updated by: CHU de Reims
Pathological features of Autosomal Dominant Polycystic Kidney disease (ADPKD) include enlarged kidney volume, a higher frequency of digestive diverticulitis and abdominal wall hernias.
Therefore, many nephrologists have concerns about the use of peritoneal dialysis (PD) in ADPKD patients.
We aimed to analyze survival and technique failure in ADPKD patients treated with PD.
Study Overview
Detailed Description
Pathological features of Autosomal Dominant Polycystic Kidney disease (ADPKD) include enlarged kidney volume, a higher frequency of digestive diverticulitis and abdominal wall hernias.
Therefore, many nephrologists have concerns about the use of peritoneal dialysis (PD) in ADPKD patients.
We aimed to analyze survival and technique failure in ADPKD patients treated with PD.
We conducted two retrospective studies on patients starting dialysis between 2000 and 2010, and based on two French registries: The French Renal Epidemiology and Information Network (REIN) and The French Language Peritoneal Dialysis Registry (RDPLF).
Study Type
Observational
Enrollment (Actual)
17350
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Reims, France, 51092
- CHU Reims
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients starting dialysis and included from the French Renal Epidemiology and Information Network (REIN) and The French Language Peritoneal Dialysis Registry (RDPLF)
Description
Iinclusion criteria :
- Patients starting dialysis
- Patients included from the French Renal Epidemiology and Information Network (REIN) and The French Language Peritoneal Dialysis Registry (RDPLF) exclusion criteria
- patients without diagnosis of nephropathy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Overall survival
Time Frame: 15 years
|
the time from the start of dialysis to death
|
15 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
technique survival
Time Frame: 15 years
|
the time from the start of dialysis to change of dialysis technique (death and transplantation were considered as competing risk)
|
15 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
February 1, 2000
Primary Completion (ACTUAL)
December 1, 2015
Study Completion (ACTUAL)
December 1, 2015
Study Registration Dates
First Submitted
May 10, 2019
First Submitted That Met QC Criteria
May 10, 2019
First Posted (ACTUAL)
May 13, 2019
Study Record Updates
Last Update Posted (ACTUAL)
May 13, 2019
Last Update Submitted That Met QC Criteria
May 10, 2019
Last Verified
May 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2018Ao005
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Polycystic Kidney Diseases
-
Palladio BiosciencesCentessa Pharmaceuticals plcTerminatedADPKD | Polycystic Kidney Disease, AdultUnited States
-
Emory UniversityPKD FoundationCompleted
-
Mario Negri Institute for Pharmacological ResearchOtsuka Pharmaceutical Italy S.r.l.CompletedAutosomal Dominant Polycystic Kidney DiseaseItaly
-
Mayo ClinicUniversity of Kansas Medical CenterCompletedAutosomal Dominant Polycystic Kidney DiseaseUnited States
-
CHU de ReimsCompletedAutosomal Dominant Polycystic Kidney DiseaseFrance
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAutosomal Dominant Polycystic Kidney DiseaseUnited States
-
Regional Hospital HolstebroAarhus University HospitalCompletedAutosomal Dominant Polycystic Kidney DiseaseDenmark
-
University Hospital, BrestUnknownAutosomal Dominant Polycystic Kidney DiseaseFrance
-
Federico II UniversityCompletedAutosomal Dominant Polycystic Kidney Disease
-
Kadmon Corporation, LLCTerminatedAutosomal Dominant Polycystic Kidney Disease (ADPKD)United States
Clinical Trials on Dialysis
-
CHU de ReimsRecruitingChronic Kidney InsufficienciesFrance
-
University Hospital, MontpellierRecruitingChronic Kidney DiseasesFrance
-
Ziv HospitalCompleted
-
University Hospital, GhentCompletedChronic Renal FailureBelgium
-
University Hospital, MontpellierAIDER- Santé; Avignon University (EA4278 - LaPEC); Pr Philippe OBERT; Dr Claire...RecruitingChronic Kidney DiseasesFrance
-
University of AarhusRecruitingChronic Kidney DiseasesDenmark
-
Dallas VA Medical CenterUnknownCardiovascular DiseaseUnited States
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI); Duke University; National...WithdrawnEnd Stage Renal DiseaseUnited States
-
University of California, Los AngelesAngiodynamics, Inc.TerminatedChronic Kidney DiseaseUnited States
-
National Taiwan University Hospital Hsin-Chu BranchUnknownHemodialysis Access Failure | Blood Pressure | Dialysis Access MalfunctionTaiwan